Homeo-GH, bone marrow-derived mesenchymal stem cells for treatment of graft-versus-host disease

Homeo-GH are bone marrow-derived mesenchymal stem cells (MSC) which have been isolated by a new protocol, called the subfractionation culturing method, to generate single-cell-derived clonal MSCs from bone marrow aspirates.  These cells are injected into graft-versus-host disease patients.